Scherjon S - Search Results

1

Triggers and appropriateness of red blood cell transfusions in the postpartum patient--a retrospective audit.

So-Osman C, Cicilia J, Brand A, Schipperus M, Berning B, Scherjon S. So-Osman C, et al. Among authors: scherjon s. Vox Sang. 2010 Jan;98(1):65-9. doi: 10.1111/j.1423-0410.2009.01231.x. Epub 2009 Aug 17. Vox Sang. 2010. PMID: 19686225

2

Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood.

Lim FT, Scherjon SA, van Beckhoven JM, Brand A, Kanhai HH, Hermans JM, Falkenburg JH. Lim FT, et al. Among authors: scherjon sa. Am J Obstet Gynecol. 2000 Nov;183(5):1144-52. doi: 10.1067/mob.2000.108848. Am J Obstet Gynecol. 2000. PMID: 11084556

3

Potential use of autologous umbilical cord blood red blood cells for early transfusion needs of premature infants.

Jansen M, Brand A, von Lindern JS, Scherjon S, Walther FJ. Jansen M, et al. Among authors: scherjon s. Transfusion. 2006 Jun;46(6):1049-56. doi: 10.1111/j.1537-2995.2006.00841.x. Transfusion. 2006. PMID: 16734824

4

A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity.

Khodabux CM, von Lindern JS, van Hilten JA, Scherjon S, Walther FJ, Brand A. Khodabux CM, et al. Among authors: scherjon s. Transfusion. 2008 Aug;48(8):1634-43. doi: 10.1111/j.1537-2995.2008.01747.x. Epub 2008 May 23. Transfusion. 2008. PMID: 18507748 Clinical Trial.

5

[Need for blood transfusion in premature infants in 2 Dutch perinatology centres particularly determined by blood sampling for diagnosis].

Hack KE, Khodabux CM, von Lindern JS, Brouwers HA, Scherjon SA, van Rijn HJ, van Hilten JA, Brand A, Page-Christiaens GC. Hack KE, et al. Among authors: scherjon sa. Ned Tijdschr Geneeskd. 2008 Jun 21;152(25):1419-25. Ned Tijdschr Geneeskd. 2008. PMID: 18624005 Dutch.

6

Benefits and risks of fetal red-cell transfusion after 32 weeks gestation.

Klumper FJ, van Kamp IL, Vandenbussche FP, Meerman RH, Oepkes D, Scherjon SA, Eilers PH, Kanhai HH. Klumper FJ, et al. Among authors: scherjon sa. Eur J Obstet Gynecol Reprod Biol. 2000 Sep;92(1):91-6. doi: 10.1016/s0301-2115(00)00430-9. Eur J Obstet Gynecol Reprod Biol. 2000. PMID: 10986440

7

Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.

van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH. van Kamp IL, et al. Acta Obstet Gynecol Scand. 2004 Aug;83(8):731-7. doi: 10.1111/j.0001-6349.2004.00394.x. Acta Obstet Gynecol Scand. 2004. PMID: 15255845 Free article.

8

Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.

Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, Kanhai HH. Van Kamp IL, et al. Am J Obstet Gynecol. 2005 Jan;192(1):171-7. doi: 10.1016/j.ajog.2004.06.063. Am J Obstet Gynecol. 2005. PMID: 15672021

9

New insights into fatigue and health-related quality of life after delivery.

Jansen AJ, Duvekot JJ, Hop WC, Essink-Bot ML, Beckers EA, Karsdorp VH, Scherjon SA, Steegers EA, van Rhenen DJ. Jansen AJ, et al. Acta Obstet Gynecol Scand. 2007;86(5):579-84. doi: 10.1080/00016340701275424. Acta Obstet Gynecol Scand. 2007. PMID: 17464587 Free article.

10

Determinants of health-related quality of life in the postpartum period after obstetric complications.

Prick BW, Bijlenga D, Jansen AJ, Boers KE, Scherjon SA, Koopmans CM, van Pampus MG, Essink-Bot ML, van Rhenen DJ, Mol BW, Duvekot JJ. Prick BW, et al. Eur J Obstet Gynecol Reprod Biol. 2015 Feb;185:88-95. doi: 10.1016/j.ejogrb.2014.11.038. Epub 2014 Dec 5. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 25541530 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page